Yasutaka Tono

First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors

Mikiya Ishihara, Yasutaka Tono, Yoshihiro Miyahara et al. · Cancer Immunology Immunotherapy · 2020 · 40 citations · Full text

Medicine, Immunology, Oncology +17

The Membrane Proteinase 3 Expression on Neutrophils Was Downregulated After Treatment With Infliximab in Patients With Rheumatoid Arthritis

Takeshi Matsumoto, Toshihiro Kaneko, Masashi Seto et al. · Clinical and Applied Thrombosis/Hemostasis · 2008 · 24 citations

Life Sciences, Immunology, Internal Medicine +17

CD204‑positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand‑1 expression

Mayuko Nagano, Kanako Saito, Yuji Kozuka et al. · Oncology Letters · 2020 · 11 citations · Full text

Medicine, Immunology, Oncology +17